AQR CAPITAL MANAGEMENT LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,573,862
+$1,418,372 QoQ
Shares Held
59,208
-0.1% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. RYTM ranks #72 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in RYTM
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,573,862 | 59,208 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $5,155,490 | 59,279 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,497,722 | 70,046 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,056,979 | 79,780 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,098,835 | 49,040 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,085,056 | 39,363 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $887,674 | 15,857 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,718,862 | 32,809 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,263,259 | 103,830 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,076,385 | 70,999 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $688,722 | 14,982 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $465,285 | 20,296 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $209,686 | 12,716 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $42,724 | 10,295 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $116,709 | 10,131 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $133,094 | 10,191 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||